Timothy Boehm v. Eli Lilly & Company
747 F.3d 501
8th Cir.2014Background
- Boehm sued Lilly for personal injury/products liability after TD developed from long-term Zyprexa use.
- Lilly relied on the learned intermediary doctrine and moved for summary judgment barring failure-to-warn claim.
- District court excluded Dr. Kruszewski’s 15% TD-risk opinion as Daubert-inadmissible.
- Record showed Boehm’s treating physicians read Lilly’s package insert and relied on it plus their own experience.
- Evidence suggested promotional activities occurred, but no proof they negated warnings or altered prescribing decisions.
- Court affirmed district court’s summary judgment, upholding warning adequacy and learned intermediary doctrine.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Admissibility of 15% TD risk testimony under Daubert | Boehm proponents claim Kruszewski’s 15% rate is admissible | Kruszewski’s 15% rate lacks reliable support | Excluded; court found insufficient scientific basis. |
| Applicability of learned intermediary doctrine to long-term TD risk | Warning inadequate for long-term use; doctors instructed poorly | Warning adequate; physicians relied on insert and experience | Applicable; summary judgment proper. |
| Overpromotion exception to learned intermediary doctrine | Excessive promotion could negate warnings | No evidence sales reps altered decisions or negated warnings | Exception not applicable; no proof of impact. |
| Whether district court properly granted summary judgment without 15% risk | Lilly’s warnings insufficient given TD risk data | Warning and medical judgment supported by record | affirmed; no genuine issue on warning adequacy. |
| Scope of evidentiary basis for TD risk in Zyprexa context | Woods study supports high TD risk for Zyprexa | Woods not designed to assess drug-specific TD risk; not reliable | Court deemed Woods inapplicable to prove 15% rate. |
Key Cases Cited
- West v. Searle & Co., 806 S.W.2d 608 (Ark. 1991) (learned intermediary doctrine and warning duty context)
- Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (U.S. 1993) (gatekeeping reliability standard for expert testimony)
- Junk v. Terminix Int’l Co., 628 F.3d 439 (8th Cir. 2010) (review standard for admissibility of expert evidence)
- Gen. Elec. Co. v. Joiner, 522 U.S. 136 (U.S. 1997) (relevance/fit and abuse of discretion in expert testimony)